Sindrome hiperprolactinemico
-
Upload
nancy-de-la-cruz -
Category
Documents
-
view
1.809 -
download
1
description
Transcript of Sindrome hiperprolactinemico
![Page 1: Sindrome hiperprolactinemico](https://reader034.fdocuments.co/reader034/viewer/2022042503/55986b521a28ab1a0b8b4739/html5/thumbnails/1.jpg)
![Page 2: Sindrome hiperprolactinemico](https://reader034.fdocuments.co/reader034/viewer/2022042503/55986b521a28ab1a0b8b4739/html5/thumbnails/2.jpg)
![Page 3: Sindrome hiperprolactinemico](https://reader034.fdocuments.co/reader034/viewer/2022042503/55986b521a28ab1a0b8b4739/html5/thumbnails/3.jpg)
EXCESO DE PRL
HIPOTALAMO
HIPOFISIS
OVARIO
Disminuyen Receptores de GNRH y
gonadotropinas
folículos / - progesterona
![Page 4: Sindrome hiperprolactinemico](https://reader034.fdocuments.co/reader034/viewer/2022042503/55986b521a28ab1a0b8b4739/html5/thumbnails/4.jpg)
• Disminuye la sensibilidad de la hipófisis a la DA.
• Verapamilo / IECAS :
• Facilitan la liberación de PRL.
• Los niveles aumentan a pocas horas de su administración retornando a valores normales a unos 2 o 3 días de dejado el fármaco. Y rara vez excede los 100 m/ml
• >200ng/ml
![Page 5: Sindrome hiperprolactinemico](https://reader034.fdocuments.co/reader034/viewer/2022042503/55986b521a28ab1a0b8b4739/html5/thumbnails/5.jpg)
REGULACIÓN DE SECRECIÓN Y CAUSAS DE HIPERPROLACTINEMIA
![Page 6: Sindrome hiperprolactinemico](https://reader034.fdocuments.co/reader034/viewer/2022042503/55986b521a28ab1a0b8b4739/html5/thumbnails/6.jpg)
![Page 7: Sindrome hiperprolactinemico](https://reader034.fdocuments.co/reader034/viewer/2022042503/55986b521a28ab1a0b8b4739/html5/thumbnails/7.jpg)
![Page 8: Sindrome hiperprolactinemico](https://reader034.fdocuments.co/reader034/viewer/2022042503/55986b521a28ab1a0b8b4739/html5/thumbnails/8.jpg)
Galactorrea en presencia de menstruaciones normales no esta asociada a hiperprolactinemia
• Galactorrea*PRL
• Oligomenorrea
• Amenorrea (>100ng/ml)
• infertilidadFSH Y LH
• Lubricación vaginal reducida
• Dispareunia
• Osteoporosis*
• Hirsutismo*
ESTROGENOS
![Page 9: Sindrome hiperprolactinemico](https://reader034.fdocuments.co/reader034/viewer/2022042503/55986b521a28ab1a0b8b4739/html5/thumbnails/9.jpg)
![Page 10: Sindrome hiperprolactinemico](https://reader034.fdocuments.co/reader034/viewer/2022042503/55986b521a28ab1a0b8b4739/html5/thumbnails/10.jpg)
![Page 11: Sindrome hiperprolactinemico](https://reader034.fdocuments.co/reader034/viewer/2022042503/55986b521a28ab1a0b8b4739/html5/thumbnails/11.jpg)
![Page 12: Sindrome hiperprolactinemico](https://reader034.fdocuments.co/reader034/viewer/2022042503/55986b521a28ab1a0b8b4739/html5/thumbnails/12.jpg)
N Engl J Med 2003;349:2035-41.
Microprolactinoma* Macroprolactinoma
4 mm diámetro 1 cm diámetro
![Page 13: Sindrome hiperprolactinemico](https://reader034.fdocuments.co/reader034/viewer/2022042503/55986b521a28ab1a0b8b4739/html5/thumbnails/13.jpg)
Canadian Medical Association Journal Volume 169 • Number 6 • September 16, 2003
![Page 14: Sindrome hiperprolactinemico](https://reader034.fdocuments.co/reader034/viewer/2022042503/55986b521a28ab1a0b8b4739/html5/thumbnails/14.jpg)
Canadian Medical Association Journal Volume 169 • Number 6 • September 16, 2003
Alteraciones visualesCefaleaDeficit neurologico
![Page 15: Sindrome hiperprolactinemico](https://reader034.fdocuments.co/reader034/viewer/2022042503/55986b521a28ab1a0b8b4739/html5/thumbnails/15.jpg)